Sun.Jul 11, 2021

article thumbnail

Oncotarget: LAPAS1 is required for S phase progression and cell proliferation

Scienmag

They identify LAPAS1 as a novel E2F-regulated lncRNA that has a potential role in human cancer and regulates cell-cycle progression and cell proliferation Credit: Correspondence to – Doron Ginsberg – doron.ginsberg@biu.ac.il Oncotarget published “A novel E2F1-regulated lncRNA, LAPAS1, is required for S phase progression and cell proliferation” which reported that long non-coding RNAs are major […].

article thumbnail

Inclusion and Diversity is Paramount to Sana’s Patient-Centric Culture

BioSpace

Sana Biotechnology, a gene and cell therapy hybrid whose mission is to create and deliver engineered cells as medicines for patients, puts the “I” first in Inclusion, Diversity and Equity (IDE).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Program increases underrepresented groups in biomedical data science, quantitative biology

Scienmag

Credit: Fisk University FUTURE-MINDS-QB, a bridge program streamlining a path from a master’s degree at Fisk University, a historically Black university in Nashville, to a doctoral degree at University of Illinois Urbana-Champaign, has received a T32 training grant from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH).

Doctors 87
article thumbnail

Evidence Building for a Mix and Match Approach to COVID-19 Vaccines

BioSpace

Morgan had determined that adding one dose of the Moderna or Pfizer-BioNTech mRNA vaccine to one of Oxford-AstraZeneca’s viral vector technology would equal stronger immunity.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

New electronic paper displays brilliant colours

Scienmag

Credit: Image: Marika Gugole/Chalmers University of Technology Imagine sitting out in the sun, reading a digital screen as thin as paper, but seeing the same image quality as if you were indoors. Thanks to research from Chalmers University of Technology, Sweden, it could soon be a reality. A new type of reflective screen – sometimes […].

article thumbnail

FDA Gives Enochian Positive Signal on Hijack RNA Treatment for HBV

BioSpace

?The company said that it values the FDA's feedback and is happy that the agency has accepted its request to provide insights on its Hepatitis B development program.

RNA 85

More Trending

article thumbnail

Galapagos Touts Positive Post-Hoc Data, but Likely Won’t Gun for US Approval

BioSpace

While the drug showed significant improvement in patients on a 200mg daily dose of filgotinib, it may not be promoted in the states any time soon.

Drugs 89
article thumbnail

Oncotarget: Inhibitory effects of Tomivosertib in acute myeloid leukemia

Scienmag

These Oncotarget findings demonstrate that Tomivosertib exhibits potent anti-leukemic properties on AML cells and support the development of clinical translational efforts involving the use of this drug Credit: Correspondence to – Leonidas C. Platanias – l-platanias@northwestern.edu Oncotarget published “Inhibitory effects of Tomivosertib in acute myeloid leukemia” which reported that the authors evaluated the therapeutic potential […].

article thumbnail

Experts Push Back on Pfizer Claim That COVID-19 Booster is Necessary Now

BioSpace

?HHS issued their announcement, saying, “Americans who have been fully vaccinated do not need a booster shot at this time.

article thumbnail

Care home residents are at risk of COVID-19 even after being fully vaccinated

Scienmag

Care homes need to be vigilant for outbreaks of COVID-19, even after residents have received two doses of the vaccine, according to new research being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) held online this year. Long-term care facilities, such as care homes with elderly residents with multiple underlying conditions, […].

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Bayer Wins Approval for CKD Drug

BioSpace

The first nonsteroidal mineralocorticoid receptor antagonist (MRA) is approved for adults with chronic kidney disease associated with type 2 diabetes.

Drugs 83
article thumbnail

Outbreaks of COVID-19 in French nursing homes traced back to staff

Scienmag

COVID-19 outbreaks in French nursing homes almost certainly started in staff – and none of measures put in place stopped the virus from taking hold, new research being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), held online this year, shows. Residents of long-term care facilities represent a small fraction of […].

Nurses 75
article thumbnail

A Closer Look at the Pricing Strategy Behind Biogen's Aduhelm

BioSpace

Adulhelm's proposed price tag of $56,000 per patient per year is hardly the most expensive drug on the market, but controversy regarding packaging and pricing continues.

article thumbnail

Just 25 mega-cities produce 52% of the world’s urban greenhouse gas emissions

Scienmag

New research published by the open access publisher Frontiers inventories greenhouse gas emissions of 167 globally distributed cities. The study shows that just 25 mega-cities produce 52% of the greenhouse gas emissions from the studied cities. In 2015, 170 countries worldwide adopted the Paris Agreement, with the goal limiting the average global temperature increase to […].

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

In Response to Rare Guillain-Barré Cases, FDA Plans New Warning for J&J COVID-19 Vaccine

BioSpace

Approximately 100 preliminary reports of GBS have been identified out of 12.8 million doses of the J&J vaccine in the U.S., according to the Centers for Disease Control and Prevention.

article thumbnail

Addressing social needs may help mitigate distress and improve the health of women with cancer

Scienmag

A new study published by Wiley early online in CANCER, a peer-reviewed journal of the American Cancer Society, has identified unmet social needs in women with gynecologic cancer that could be addressed to improve care for patients and lessen disparities. For example, identifying patients who reported needing help with reading hospital materials resulted in the […].

article thumbnail

Clinical Catch-Up: July 5-9

BioSpace

Last week presented a fair number of clinical trial news. Read on for more information.

article thumbnail

High-tech toilets could spread antibiotic-resistant superbugs in hospitals, Japanese study suggests

Scienmag

Water-jet nozzles in electric toilets–commonly used in Japan and other parts of Asia–may be reservoirs for multidrug-resistant Pseudomonas aeruginosa (MDRP) in hospitals, increasing the risk of dangerous germ transmission among patients, according to new research being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) held online this year. “This is the […].

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

FDA Approves J&J’s Darzalex Faspro for Sixth Multiple Myeloma Indication

BioSpace

It was based on data from the APOLLO trial showing the drug significantly decreased the risk of progression or death by 37% compared to dexamethasone alone.

article thumbnail

Hepatitis C vaccine could be rolled out within five years, says Nobel Prize winner who discovered virus

Scienmag

A vaccine to protect against infection with hepatitis C could be in use within 5 years, says Professor Sir Michael Houghton, who won the Nobel Prize for Medicine and Physiology along with three other scientists for discovering the hepatitis C virus (HCV) in 1989. Sir Michael will discuss the development of a vaccine in a […].

article thumbnail

Activist Investors Seek to Steer Control of Phoenixus Away from Jailed "Pharma Bro"

BioSpace

A former CEO of Vyera and other activist investors are pushing a slate of new company directors who would steer control of Phoenixus and Vyera away from Shkreli.

72
article thumbnail

New study shows that silver foil could reduce the risk of infection in hospitals

Scienmag

New research presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) taking place online (9-12 July) shows that covering high-touch (the most regularly touched) surfaces in hospitals with silver-impregnated foil could significantly reduce levels of contamination by clinically important bacterial pathogens.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Novo Nordisk Takes Over Prothena's ATTR Amyloidosis Business for $1.2 Billion

BioSpace

Novo Nordisk will take over Prothena's wholly-owned subsidiary and gain full global intellectual property rights and other related rights for the latter's ATTR amyloidosis business and pipeline.

69
article thumbnail

Protein appears to prevent tumor cells from spreading via blood vessels

Scienmag

Johns Hopkins researchers describe protein regulating key step in cancer metastasis Credit: Johns Hopkins University Researchers have identified a specialized protein that appears to help prevent tumor cells from entering the bloodstream and spreading to other parts of the body. “We have discovered that this protein, TRPM7, senses the pressure of fluid flowing in the […].

Protein 69
article thumbnail

Biotech IPO Stampede Continues with Five More Companies

BioSpace

The 2021 IPO stampede continues with five more companies aiming to trade on a stock exchange.

88
article thumbnail

Oncotarget: Modulating Tau Post-translational modifications and cytoskeletal network

Scienmag

EGCG, a green tea polyphenol, as a modulator of in vitro methylglyoxal-induced Tau glycation and its impact on reducing advanced glycation end products in neuroblastoma cells Credit: Correspondence to – Subashchandrabose Chinnathambi – s.chinnathambi@ncl.res.in Oncotarget published “Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network” which reported that the chemical modulators of Tau PTMs, such as […].

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress

The Pharma Data

Analysis of Safety and Efficacy for up to 2.5 years with TAKHYZRO is Consistent with Initial Period of Treatment, Building on Growing Body of Evidence on the Long-term Safety and Efficacy Final Patient Subgroup Analysis Suggests Reductions of HAE Attacks Across Range of Patient Demographics and Disease Characteristics with TAKHZYRO. Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (“Takeda”) today announced results from two final analyses from the Phase 3 HELP (Hereditary Angioedema L

article thumbnail

New patent expiration for Baxter Hlthcare drug BREVIBLOC IN PLASTIC CONTAINER

Drug Patent Watch

Annual Drug Patent Expirations for BREVIBLOC+IN+PLASTIC+CONTAINER Brevibloc In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from three suppliers. There…. The post New patent expiration for Baxter Hlthcare drug BREVIBLOC IN PLASTIC CONTAINER appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Mirikizumab Up-Regulates Genes Associated with Mucosal Healing in Ulcerative Colitis for Up to One Year in Phase 2 Study

The Pharma Data

Eli Lilly and Company (NYSE: LLY) announced new Phase 2 data showing that gene expression changes induced by mirikizumab in patients with ulcerative colitis (UC) over a 12-week induction treatment were maintained for up to one year. These gene transcript changes, which were unique among those who responded to mirikizumab compared to placebo, were associated with mucosal healing, indicating that mirikizumab affects a distinct molecular healing pathway, compared to the spontaneous healing that occ

article thumbnail

New patent expiration for Baxter Hlthcare drug BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER

Drug Patent Watch

Annual Drug Patent Expirations for BREVIBLOC+DOUBLE+STRENGTH+IN+PLASTIC+CONTAINER Brevibloc Double Strength In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from three…. The post New patent expiration for Baxter Hlthcare drug BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.